To include your compound in the COVID-19 Resource Center, submit it here.

VEGF: Treading a fine line

The notion of using angiogenesis to treat cardiovascular conditions such as peripheral artery disease treads a fine line between therapy and malignancy because several disease conditions are associated with angiogenesis.

In atherosclerosis, for example, angiogenesis occurs during the formation of plaques. Last week, scientists at Stanford University and the World Health Organization published in

Read the full 549 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE